Abbott tells us it has received U.S. FDA approval for the fourth generation of of its MitraClip™ heart valve repair device to treat … continue reading “U.S. Approval for Next-Generation MitraClip®”
Cardio
FDA Clearance of Steerable Introducer for Transseptal Access/Delivery
BioCardia shows its newly cleared transseptal access system at Heart Rhythm Society congress in San Francisco
Promising Study Outcomes for Edwards Aortic Valves with RESILIA Tissue
COMMENCE trial four-year data presented at the AATS 99th Annual Meeting
Collaboration Boosts Early Stem Cell Therapy for Myocardial Infarction Patients
Company collaboration hopes to accelerate positive study outcome
New WatchPAT™ Sleep Apnea Scoring Guidelines Unveiled at SLEEP 2018
Evidence-based guidelines based on a large-scale sleep apnea study demonstrate WatchPAT’s efficiency and accuracy
First Patient in Biosense Webster’s Multi-Electrode RF Balloon Catheter Study
Multicenter study will evaluate balloon ablation catheter for safety and effectiveness in achieving pulmonary vein isolation in paroxysmal AF treatment
Enrollment Complete in Thermocool Smarttouch® SF Catheter US IDE Study
Persistent Paroxysmal Atrial Fibrillation in focus for heart rhythm specialist
First-in-Man Study Demonstrates Safety and Efficacy of SELUTION™ DCB in Long Lesions
Findings confirm the efficacy of the SELUTION sirolimus-coated technology
Endologix Completes ELEVATE IDE Clinical Study Enrollment
Endovascular stent graft study promises clinical results later this year
FDA Nod for CardiAmp Cell Therapy IDE Trial in Chronic Myocardial Ischemia
“It is a step towards developing a new treatment strategy that could have tremendous benefit for patients with refractory angina”
First Patient Enrolled in U.S. LAA Stroke Study
Biosense Webster, Inc. launches U.S. study to evaluate the safety and efficacy of the WaveCrest® Left Atrial Appendage Occlusion System
“Exceptional” Six-Week Stent Results Offer Hope to Severe Tricuspid Regurgitation Patients
Two implantations of GATE™ Atrioventricular Valved Stent (AVS) in compassionate cases
Abbott’s MitraClip First Transcatheter Mitral Valve Repair Device Approved in Japan
Japanese study data underpins approval
HighLife Closes €12.3 Million Financing Round
Plans see acceleration of the company’s clinical and R&D program
New Funding Will Fuel Claret Medical’s U.S. Plans for Sentinel® Cerebral Protection System
Company closes $14.5million funding round
Green Light for BioCardia Study Following Interim Safety Analysis
Phase 3 260 patient stem cell therapy clinical trial back on track